Healthpeak Properties (NYSE:DOC) Trading 12.5% Higher on Earnings Beat

Key Points

• Shares jumped 12.5% after Healthpeak beat expectations with Q results — EPS $0.45 vs $0.43 est and revenue $738.8M vs $694.6M (+7.1% YoY) — and set FY2026 guidance of $1.710–$1.750 EPS.
• The company declared a monthly dividend of $0.1017 (payable June 26, ex-dividend June 15) implying about a 6.5% yield
• Analysts are mixed: the consensus rating is "Hold" with an average price target of $18.04 after several cuts, leaving the stock trading roughly in line with street expectations.

Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) traded up 12.5% during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $18.73 and last traded at $18.57. 3,077,172 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 8,894,225 shares. The stock had previously closed at $16.51.

The real estate investment trust reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business had revenue of $738.78 million during the quarter, compared to analyst estimates of $694.59 million. During the same period in the previous year, the business earned $0.46 EPS. Healthpeak Properties's revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a $0.1017 dividend. This represents a c) annualized dividend and a yield of 6.5%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties's dividend payout ratio (DPR) is presently 1,220.00%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Citigroup cut their price target on shares of Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating for the company in a report on Wednesday, April 1st. UBS Group assumed coverage on shares of Healthpeak Properties in a report on Monday, April 20th. They issued a "neutral" rating and a $17.00 price target for the company. Wells Fargo & Company reissued a "positive" rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Weiss Ratings reissued a "hold (c-)" rating on shares of Healthpeak Properties in a report on Friday, April 24th. Finally, Morgan Stanley cut their price target on shares of Healthpeak Properties from $21.00 to $18.00 and set an "overweight" rating for the company in a report on Tuesday, April 28th. Five research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $18.04.

Institutional Trading of Healthpeak Properties

A number of hedge funds have recently made changes to their positions in DOC. Argent Advisors Inc. purchased a new position in Healthpeak Properties in the 3rd quarter worth $1,536,000. Twin City Private Wealth LLC purchased a new position in Healthpeak Properties in the 3rd quarter worth $1,148,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Healthpeak Properties by 7.0% in the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust's stock worth $37,063,000 after purchasing an additional 126,322 shares during the period. JPMorgan Chase & Co. raised its position in Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock worth $540,730,000 after purchasing an additional 8,212,504 shares during the period. Finally, Bank of New York Mellon Corp raised its position in Healthpeak Properties by 8.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 6,754,147 shares of the real estate investment trust's stock worth $129,342,000 after purchasing an additional 525,875 shares during the period. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Performance

The company has a market cap of $13.08 billion, a PE ratio of 187.46, a PEG ratio of 2.25 and a beta of 1.00. The business's 50-day moving average is $16.93 and its 200 day moving average is $17.14. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.